<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
85268-801-03
</NDCCode>
<PackageDescription>
10 BAG in 1 CASE (85268-801-03) / 1000 mL in 1 BAG (85268-801-02)
</PackageDescription>
<NDC11Code>
85268-0801-03
</NDC11Code>
<ProductNDC>
85268-801
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Sodium Chloride 0.9%
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Sodium Chloride
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20250307
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Huaren Pharmaceutical (Rizhao) Co., Ltd.
</LabelerName>
<SubstanceName>
SODIUM CHLORIDE
</SubstanceName>
<StrengthNumber>
9
</StrengthNumber>
<StrengthUnit>
g/mL
</StrengthUnit>
<Pharm_Classes>
Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-05-20
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250307
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>